Hattori, K., Sakata‐Yanagimoto, M., Suehara, Y., Yokoyama, Y., Kato, T., Kurita, N., . . . Chiba, S. (2017). Clinical significance of disease‐specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Cancer Sci.
Chicago ZitierstilHattori, Keiichiro, et al. "Clinical Significance of Disease‐specific MYD88 Mutations in Circulating DNA in Primary Central Nervous System Lymphoma." Cancer Sci 2017.
MLA ZitierstilHattori, Keiichiro, et al. "Clinical Significance of Disease‐specific MYD88 Mutations in Circulating DNA in Primary Central Nervous System Lymphoma." Cancer Sci 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.